Table 2 The frequency distribution of Parkinson’s disease gene mRNA relative expression
From: Status of the Parkinson’s disease gene family expression in non-small-cell lung cancer
Fold | PARK1/4 SCNA | PARK2 Parkin | PARK5 UCHL1 | PARK6 PINK1 | PARK7 DJ-1 | PARK8 LRRK2 | PARK9 ATP13A2 | PARK15 FBXO7 | GBA |
|---|---|---|---|---|---|---|---|---|---|
(n = 114) | (n = 114) | (n = 114) | (n = 114) | (n = 114) | (n = 114) | (n = 114) | (n = 114) | (n = 114) | |
≤0.5 | 23 | 18 | 1 | 9 | 9 | 22 | 5 | 14 | 6 |
(20.18 %) | (15.79 %) | (0.88 %) | (7.89 %) | (7.89 %) | (19.30 %) | (4.39 %) | (12.28 %) | (5.26 %) | |
0.5–1.5 | 45 | 22 | 9 | 10 | 25 | 37 | 9 | 45 | 9 |
(39.47 %) | (19.30 %) | (7.89 %) | (8.77 %) | (21.93 %) | (32.46 %) | (7.89 %) | (39.47 %) | (7.89 %) | |
≥1.5 | 46 | 74 | 104 | 95 | 80 | 55 | 100 | 55 | 99 |
(40.35 %) | (64.91 %) | (91.23 %) | (83.33 %) | (70.18 %) | (48.25 %) | (87.72 %) | (48.25 %) | (86.84 %) | |
≥5 | 2 | 19 | 91 | 45 | 14 | 15 | 66 | 9 | 56 |
(1.75 %) | (16.67 %) | (79.82 %) | (39.47 %) | (12.28 %) | (13.16 %) | (57.89 %) | (7.89 %) | (49.12 %) | |
≥10 | 0 | 4 | 70 | 16 | 2 | 2 | 39 | 0 | 23 |
(0.00 %) | (3.51 %) | (61.40 %) | (14.04 %) | (1.75 %) | (1.75 %) | (34.21 %) | (0.00 %) | (20.18 %) |